AGAP2-AS1 gene expression was increased in P, as compared to NP low-risk ccRCC, and, accordingly, associated with unfavorable prognosis in ccRCC at large (p-value = 2.8E−6). This evidence concerns the gene AGAP2 and nonpapillary renal cell carcinoma.